Aviva Schwartz/LinkedIn
Sep 15, 2025, 16:39
Vasculearn Network 2025 Northeast Anticoagulation Stewardship Council Meeting: Aviva Schwartz Thanks the Experts!
Aviva Schwartz, Director of Education at Vasculearn Network, shared on LinkedIn:
”This past Friday, we welcomed pharmacists, nurses, and physicians to the Vasculearn Network 2025 Northeast Anticoagulation Stewardship Council Meeting at the Massachusetts Medical Society.
From practice-changing trial updates to AI-driven stewardship tools, case-based learning, and a forward-looking discussion on gene therapy, our expert faculty delivered key education and insights that will help improve patient safety and outcomes in antithrombotic management.
A huge thank you to:
- Our speakers, Gregory Piazza, John Fanikos, Ryan Mize, Rajesh Patel, Andrea Van Beek, Daniel Guerra Jr., and Nathan Connell
- Our Planning Committee and case presenters, John Fanikos, Marilyn Hill, Kathleen Sargent, Katelyn Sylvester, and Tara Lech
- The VLN staff, especially Kathryn Mikkelsen, John Fanikos, and Courtney Anderson for making this event possible for another year
- Our attendees for contributing your experience to this growing community of stewardship leaders…all day on a Friday no less!”
Stay updated on the latest news with Hemostasis Today.
-
Nov 4, 2025, 09:26Courtney Lawrence: One of Our Most Popular American Red Cross SUCCESS Talks is Just Around the Corner!
-
Nov 4, 2025, 09:21New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
-
Nov 4, 2025, 09:20Yazan Abou Ismail to Present Insights on AI Models in TTP at 67th ASH Annual Meeting
-
Nov 4, 2025, 09:17David Calvet Canut on Takeda's HyHub: A Shift Toward Patient-Centered Biologics
-
Nov 4, 2025, 09:16Samantha Nelson Encourages You to Share Your Experience on World Thrombosis Day
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!
Nov 4, 2025, 09:20
Nov 4, 2025, 09:17
Nov 4, 2025, 09:14
Nov 4, 2025, 09:11
Nov 4, 2025, 09:08